Article info

Download PDFPDF

From the origin of NASH to the future of metabolic fatty liver disease

Authors

  • Andreas Geier Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Bayern, Germany PubMed articlesGoogle scholar articles
  • Dina Tiniakos Department of Pathology, Aretaieion Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece & Translational & Clinical Research Institute; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Helmut Denk Institute of Pathology, Medical University of Graz, Graz, Steiermark, Austria PubMed articlesGoogle scholar articles
  • Michael Trauner Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Wien, Wien, Austria PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Andreas Geier, Medical Center, Division of Hepatology, University of Würzburg, Wurzburg, Bayern, Germany; Geier_A2{at}medizin.uni-wuerzburg.de
View Full Text

Citation

Geier A, Tiniakos D, Denk H, et al
From the origin of NASH to the future of metabolic fatty liver disease

Publication history

  • Received September 28, 2020
  • Revised January 13, 2021
  • Accepted February 5, 2021
  • First published February 25, 2021.
Online issue publication 
July 12, 2021

Article Versions

Related Data

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.